Skip to Primary Navigation

DOJ, DEA reclassify marijuana products as Schedule I drugs

A photo of a gold-colored marijuana leaf hanging outside of shop.
Photo: Smith Collection/Gado/Getty Images

The changes move products containing marijuana to a less restrictive category, taking significant strides toward the legalization of the drug itself.

Significant steps toward changing how the federal government regulates FDA-approved marijuana products have been announced by the US Department of Justice (DOJ) and the Drug Enforcement Administration (DEA).

According to an April 23 order from the DOJ, FDA-approved drugs that contain marijuana, as well as medical marijuana products regulated by state